 | • レポートコード：MRC2-11QY04839 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は治療用血漿交換のグローバル市場について調査・分析したレポートです。種類別（神経障害、腎障害、血液疾患、代謝障害、その他）市場規模、用途別（病院、専門クリニック、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別治療用血漿交換の競争状況、市場シェア ・世界の治療用血漿交換市場：種類別市場規模 2015年-2020年（神経障害、腎障害、血液疾患、代謝障害、その他） ・世界の治療用血漿交換市場：種類別市場規模予測 2021年-2026年（神経障害、腎障害、血液疾患、代謝障害、その他） ・世界の治療用血漿交換市場：用途別市場規模 2015年-2020年（病院、専門クリニック、外来外科センター） ・世界の治療用血漿交換市場：用途別市場規模予測 2021年-2026年（病院、専門クリニック、外来外科センター） ・北米の治療用血漿交換市場分析：米国、カナダ ・ヨーロッパの治療用血漿交換市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの治療用血漿交換市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の治療用血漿交換市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの治療用血漿交換市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Asahi Kasei Corporation、Baxter International、Terumo Corporation、B. Braun、Fresenius Kabi、Kawasumi Laboratories、Haemonetics Corporation、Cerus Corporation、Hemacare Corporation、Medica S.p.A. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely performed in the treatment of various chronic diseases as first line or as second line of therapy or as a supportive treatment.
Therapeutic plasma exchange (TPE) has wide applications in the treatment of neurological, renal, hematological, and metabolic disorders. The indications for using therapeutic plasma exchange procedures as a line of treatment are regulated through guidelines provided by the American Society for Apheresis (ASFA). It categorizes the indications in four parts: category I to IV. Category I and II depict TPE as first or second line of treatment for many neurological, renal, and hematological disorders such as chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, Guillain-Barre syndrome, and thrombotic thrombocytopenic purpura (TTP).
Market Analysis and Insights: Global Therapeutic Plasma Exchange Market
The global Therapeutic Plasma Exchange market size is projected to reach US$ 191.2 million by 2026, from US$ 173.7 million in 2020, at a CAGR of 9.3%% during 2021-2026.
Global Therapeutic Plasma Exchange Scope and Market Size
Therapeutic Plasma Exchange market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Plasma Exchange market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Asahi Kasei Corporation
Baxter International
Terumo Corporation
B. Braun
Fresenius Kabi
Kawasumi Laboratories
Haemonetics Corporation
Cerus Corporation
Hemacare Corporation
Medica S.p.A.
Market segment by Type, the product can be split into
Neurological Disorders
Renal Disorders
Hematology Disorders
Metabolic Disorders
Others
Market segment by Application, split into
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Therapeutic Plasma Exchange Revenue
1.4 Market by Type
1.4.1 Global Therapeutic Plasma Exchange Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Neurological Disorders
1.4.3 Renal Disorders
1.4.4 Hematology Disorders
1.4.5 Metabolic Disorders
1.4.6 Others
1.5 Market by Application
1.5.1 Global Therapeutic Plasma Exchange Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Plasma Exchange Market Perspective (2015-2026)
2.2 Global Therapeutic Plasma Exchange Growth Trends by Regions
2.2.1 Therapeutic Plasma Exchange Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Therapeutic Plasma Exchange Historic Market Share by Regions (2015-2020)
2.2.3 Therapeutic Plasma Exchange Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Therapeutic Plasma Exchange Market Growth Strategy
2.3.6 Primary Interviews with Key Therapeutic Plasma Exchange Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Plasma Exchange Players by Market Size
3.1.1 Global Top Therapeutic Plasma Exchange Players by Revenue (2015-2020)
3.1.2 Global Therapeutic Plasma Exchange Revenue Market Share by Players (2015-2020)
3.1.3 Global Therapeutic Plasma Exchange Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Therapeutic Plasma Exchange Market Concentration Ratio
3.2.1 Global Therapeutic Plasma Exchange Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Therapeutic Plasma Exchange Revenue in 2019
3.3 Therapeutic Plasma Exchange Key Players Head office and Area Served
3.4 Key Players Therapeutic Plasma Exchange Product Solution and Service
3.5 Date of Enter into Therapeutic Plasma Exchange Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Therapeutic Plasma Exchange Historic Market Size by Type (2015-2020)
4.2 Global Therapeutic Plasma Exchange Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Therapeutic Plasma Exchange Market Size by Application (2015-2020)
5.2 Global Therapeutic Plasma Exchange Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Therapeutic Plasma Exchange Market Size (2015-2020)
6.2 Therapeutic Plasma Exchange Key Players in North America (2019-2020)
6.3 North America Therapeutic Plasma Exchange Market Size by Type (2015-2020)
6.4 North America Therapeutic Plasma Exchange Market Size by Application (2015-2020)
7 Europe
7.1 Europe Therapeutic Plasma Exchange Market Size (2015-2020)
7.2 Therapeutic Plasma Exchange Key Players in Europe (2019-2020)
7.3 Europe Therapeutic Plasma Exchange Market Size by Type (2015-2020)
7.4 Europe Therapeutic Plasma Exchange Market Size by Application (2015-2020)
8 China
8.1 China Therapeutic Plasma Exchange Market Size (2015-2020)
8.2 Therapeutic Plasma Exchange Key Players in China (2019-2020)
8.3 China Therapeutic Plasma Exchange Market Size by Type (2015-2020)
8.4 China Therapeutic Plasma Exchange Market Size by Application (2015-2020)
9 Japan
9.1 Japan Therapeutic Plasma Exchange Market Size (2015-2020)
9.2 Therapeutic Plasma Exchange Key Players in Japan (2019-2020)
9.3 Japan Therapeutic Plasma Exchange Market Size by Type (2015-2020)
9.4 Japan Therapeutic Plasma Exchange Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Therapeutic Plasma Exchange Market Size (2015-2020)
10.2 Therapeutic Plasma Exchange Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Therapeutic Plasma Exchange Market Size by Type (2015-2020)
10.4 Southeast Asia Therapeutic Plasma Exchange Market Size by Application (2015-2020)
11 India
11.1 India Therapeutic Plasma Exchange Market Size (2015-2020)
11.2 Therapeutic Plasma Exchange Key Players in India (2019-2020)
11.3 India Therapeutic Plasma Exchange Market Size by Type (2015-2020)
11.4 India Therapeutic Plasma Exchange Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Therapeutic Plasma Exchange Market Size (2015-2020)
12.2 Therapeutic Plasma Exchange Key Players in Central & South America (2019-2020)
12.3 Central & South America Therapeutic Plasma Exchange Market Size by Type (2015-2020)
12.4 Central & South America Therapeutic Plasma Exchange Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Asahi Kasei Corporation
13.1.1 Asahi Kasei Corporation Company Details
13.1.2 Asahi Kasei Corporation Business Overview
13.1.3 Asahi Kasei Corporation Therapeutic Plasma Exchange Introduction
13.1.4 Asahi Kasei Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020))
13.1.5 Asahi Kasei Corporation Recent Development
13.2 Baxter International
13.2.1 Baxter International Company Details
13.2.2 Baxter International Business Overview
13.2.3 Baxter International Therapeutic Plasma Exchange Introduction
13.2.4 Baxter International Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.2.5 Baxter International Recent Development
13.3 Terumo Corporation
13.3.1 Terumo Corporation Company Details
13.3.2 Terumo Corporation Business Overview
13.3.3 Terumo Corporation Therapeutic Plasma Exchange Introduction
13.3.4 Terumo Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.3.5 Terumo Corporation Recent Development
13.4 B. Braun
13.4.1 B. Braun Company Details
13.4.2 B. Braun Business Overview
13.4.3 B. Braun Therapeutic Plasma Exchange Introduction
13.4.4 B. Braun Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.4.5 B. Braun Recent Development
13.5 Fresenius Kabi
13.5.1 Fresenius Kabi Company Details
13.5.2 Fresenius Kabi Business Overview
13.5.3 Fresenius Kabi Therapeutic Plasma Exchange Introduction
13.5.4 Fresenius Kabi Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.5.5 Fresenius Kabi Recent Development
13.6 Kawasumi Laboratories
13.6.1 Kawasumi Laboratories Company Details
13.6.2 Kawasumi Laboratories Business Overview
13.6.3 Kawasumi Laboratories Therapeutic Plasma Exchange Introduction
13.6.4 Kawasumi Laboratories Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.6.5 Kawasumi Laboratories Recent Development
13.7 Haemonetics Corporation
13.7.1 Haemonetics Corporation Company Details
13.7.2 Haemonetics Corporation Business Overview
13.7.3 Haemonetics Corporation Therapeutic Plasma Exchange Introduction
13.7.4 Haemonetics Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.7.5 Haemonetics Corporation Recent Development
13.8 Cerus Corporation
13.8.1 Cerus Corporation Company Details
13.8.2 Cerus Corporation Business Overview
13.8.3 Cerus Corporation Therapeutic Plasma Exchange Introduction
13.8.4 Cerus Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.8.5 Cerus Corporation Recent Development
13.9 Hemacare Corporation
13.9.1 Hemacare Corporation Company Details
13.9.2 Hemacare Corporation Business Overview
13.9.3 Hemacare Corporation Therapeutic Plasma Exchange Introduction
13.9.4 Hemacare Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.9.5 Hemacare Corporation Recent Development
13.10 Medica S.p.A.
13.10.1 Medica S.p.A. Company Details
13.10.2 Medica S.p.A. Business Overview
13.10.3 Medica S.p.A. Therapeutic Plasma Exchange Introduction
13.10.4 Medica S.p.A. Revenue in Therapeutic Plasma Exchange Business (2015-2020)
13.10.5 Medica S.p.A. Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Therapeutic Plasma Exchange Key Market Segments
Table 2. Key Players Covered: Ranking by Therapeutic Plasma Exchange Revenue
Table 3. Ranking of Global Top Therapeutic Plasma Exchange Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Therapeutic Plasma Exchange Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Neurological Disorders
Table 6. Key Players of Renal Disorders
Table 7. Key Players of Hematology Disorders
Table 8. Key Players of Metabolic Disorders
Table 9. Key Players of Others
Table 10. Global Therapeutic Plasma Exchange Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Therapeutic Plasma Exchange Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Therapeutic Plasma Exchange Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Therapeutic Plasma Exchange Market Share by Regions (2015-2020)
Table 14. Global Therapeutic Plasma Exchange Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Therapeutic Plasma Exchange Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Therapeutic Plasma Exchange Market Growth Strategy
Table 20. Main Points Interviewed from Key Therapeutic Plasma Exchange Players
Table 21. Global Therapeutic Plasma Exchange Revenue by Players (2015-2020) (Million US$)
Table 22. Global Therapeutic Plasma Exchange Market Share by Players (2015-2020)
Table 23. Global Top Therapeutic Plasma Exchange Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Plasma Exchange as of 2019)
Table 24. Global Therapeutic Plasma Exchange by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Therapeutic Plasma Exchange Product Solution and Service
Table 27. Date of Enter into Therapeutic Plasma Exchange Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Therapeutic Plasma Exchange Market Size by Type (2015-2020) (Million US$)
Table 30. Global Therapeutic Plasma Exchange Market Size Share by Type (2015-2020)
Table 31. Global Therapeutic Plasma Exchange Revenue Market Share by Type (2021-2026)
Table 32. Global Therapeutic Plasma Exchange Market Size Share by Application (2015-2020)
Table 33. Global Therapeutic Plasma Exchange Market Size by Application (2015-2020) (Million US$)
Table 34. Global Therapeutic Plasma Exchange Market Size Share by Application (2021-2026)
Table 35. North America Key Players Therapeutic Plasma Exchange Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Therapeutic Plasma Exchange Market Share (2019-2020)
Table 37. North America Therapeutic Plasma Exchange Market Size by Type (2015-2020) (Million US$)
Table 38. North America Therapeutic Plasma Exchange Market Share by Type (2015-2020)
Table 39. North America Therapeutic Plasma Exchange Market Size by Application (2015-2020) (Million US$)
Table 40. North America Therapeutic Plasma Exchange Market Share by Application (2015-2020)
Table 41. Europe Key Players Therapeutic Plasma Exchange Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Therapeutic Plasma Exchange Market Share (2019-2020)
Table 43. Europe Therapeutic Plasma Exchange Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Therapeutic Plasma Exchange Market Share by Type (2015-2020)
Table 45. Europe Therapeutic Plasma Exchange Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Therapeutic Plasma Exchange Market Share by Application (2015-2020)
Table 47. China Key Players Therapeutic Plasma Exchange Revenue (2019-2020) (Million US$)
Table 48. China Key Players Therapeutic Plasma Exchange Market Share (2019-2020)
Table 49. China Therapeutic Plasma Exchange Market Size by Type (2015-2020) (Million US$)
Table 50. China Therapeutic Plasma Exchange Market Share by Type (2015-2020)
Table 51. China Therapeutic Plasma Exchange Market Size by Application (2015-2020) (Million US$)
Table 52. China Therapeutic Plasma Exchange Market Share by Application (2015-2020)
Table 53. Japan Key Players Therapeutic Plasma Exchange Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Therapeutic Plasma Exchange Market Share (2019-2020)
Table 55. Japan Therapeutic Plasma Exchange Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Therapeutic Plasma Exchange Market Share by Type (2015-2020)
Table 57. Japan Therapeutic Plasma Exchange Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Therapeutic Plasma Exchange Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Therapeutic Plasma Exchange Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Therapeutic Plasma Exchange Market Share (2019-2020)
Table 61. Southeast Asia Therapeutic Plasma Exchange Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Therapeutic Plasma Exchange Market Share by Type (2015-2020)
Table 63. Southeast Asia Therapeutic Plasma Exchange Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Therapeutic Plasma Exchange Market Share by Application (2015-2020)
Table 65. India Key Players Therapeutic Plasma Exchange Revenue (2019-2020) (Million US$)
Table 66. India Key Players Therapeutic Plasma Exchange Market Share (2019-2020)
Table 67. India Therapeutic Plasma Exchange Market Size by Type (2015-2020) (Million US$)
Table 68. India Therapeutic Plasma Exchange Market Share by Type (2015-2020)
Table 69. India Therapeutic Plasma Exchange Market Size by Application (2015-2020) (Million US$)
Table 70. India Therapeutic Plasma Exchange Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Therapeutic Plasma Exchange Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Therapeutic Plasma Exchange Market Share (2019-2020)
Table 73. Central & South America Therapeutic Plasma Exchange Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Therapeutic Plasma Exchange Market Share by Type (2015-2020)
Table 75. Central & South America Therapeutic Plasma Exchange Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Therapeutic Plasma Exchange Market Share by Application (2015-2020)
Table 77. Asahi Kasei Corporation Company Details
Table 78. Asahi Kasei Corporation Business Overview
Table 79. Asahi Kasei Corporation Product
Table 80. Asahi Kasei Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020) (Million US$)
Table 81. Asahi Kasei Corporation Recent Development
Table 82. Baxter International Company Details
Table 83. Baxter International Business Overview
Table 84. Baxter International Product
Table 85. Baxter International Revenue in Therapeutic Plasma Exchange Business (2015-2020) (Million US$)
Table 86. Baxter International Recent Development
Table 87. Terumo Corporation Company Details
Table 88. Terumo Corporation Business Overview
Table 89. Terumo Corporation Product
Table 90. Terumo Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020) (Million US$)
Table 91. Terumo Corporation Recent Development
Table 92. B. Braun Company Details
Table 93. B. Braun Business Overview
Table 94. B. Braun Product
Table 95. B. Braun Revenue in Therapeutic Plasma Exchange Business (2015-2020) (Million US$)
Table 96. B. Braun Recent Development
Table 97. Fresenius Kabi Company Details
Table 98. Fresenius Kabi Business Overview
Table 99. Fresenius Kabi Product
Table 100. Fresenius Kabi Revenue in Therapeutic Plasma Exchange Business (2015-2020) (Million US$)
Table 101. Fresenius Kabi Recent Development
Table 102. Kawasumi Laboratories Company Details
Table 103. Kawasumi Laboratories Business Overview
Table 104. Kawasumi Laboratories Product
Table 105. Kawasumi Laboratories Revenue in Therapeutic Plasma Exchange Business (2015-2020) (Million US$)
Table 106. Kawasumi Laboratories Recent Development
Table 107. Haemonetics Corporation Company Details
Table 108. Haemonetics Corporation Business Overview
Table 109. Haemonetics Corporation Product
Table 110. Haemonetics Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020) (Million US$)
Table 111. Haemonetics Corporation Recent Development
Table 112. Cerus Corporation Business Overview
Table 113. Cerus Corporation Product
Table 114. Cerus Corporation Company Details
Table 115. Cerus Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020) (Million US$)
Table 116. Cerus Corporation Recent Development
Table 117. Hemacare Corporation Company Details
Table 118. Hemacare Corporation Business Overview
Table 119. Hemacare Corporation Product
Table 120. Hemacare Corporation Revenue in Therapeutic Plasma Exchange Business (2015-2020) (Million US$)
Table 121. Hemacare Corporation Recent Development
Table 122. Medica S.p.A. Company Details
Table 123. Medica S.p.A. Business Overview
Table 124. Medica S.p.A. Product
Table 125. Medica S.p.A. Revenue in Therapeutic Plasma Exchange Business (2015-2020) (Million US$)
Table 126. Medica S.p.A. Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Therapeutic Plasma Exchange Market Share by Type: 2020 VS 2026
Figure 2. Neurological Disorders Features
Figure 3. Renal Disorders Features
Figure 4. Hematology Disorders Features
Figure 5. Metabolic Disorders Features
Figure 6. Others Features
Figure 7. Global Therapeutic Plasma Exchange Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Specialty Clinics Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Therapeutic Plasma Exchange Report Years Considered
Figure 12. Global Therapeutic Plasma Exchange Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Therapeutic Plasma Exchange Market Share by Regions: 2020 VS 2026
Figure 14. Global Therapeutic Plasma Exchange Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Therapeutic Plasma Exchange Market Share by Players in 2019
Figure 17. Global Top Therapeutic Plasma Exchange Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Plasma Exchange as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Therapeutic Plasma Exchange Revenue in 2019
Figure 19. North America Therapeutic Plasma Exchange Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Therapeutic Plasma Exchange Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Therapeutic Plasma Exchange Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Therapeutic Plasma Exchange Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Therapeutic Plasma Exchange Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Therapeutic Plasma Exchange Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Therapeutic Plasma Exchange Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
血液疾患診断・治療の世界市場（～2026年） Hematology, a branch of medicine, deals with the prevention, diagnosis, and treatment of blood diseases. It includes problems associated with red blood cells (RBCs), white blood cells (WBCs), platelets, bone marrow, blood vessels, spleen, lymph nodes, and proteins involved in bleeding and clotting p…- 代謝障害治療薬の世界市場（～2026年） Metabolic Disorders Therapeutics is a drug used to treat the symptoms of metabolic disorders caused by a variety of causes. Due to the increasing pressure of modern life and the spread of unhealthy lifestyles, the global metabolic disorder treatment market will continue to grow strongly during the f…
- ペプチド代謝障害治療薬の世界市場（～2026年） A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive. Peptide therapeutics are used to treat metabolic disorders owing to their stability, effici…
- 出血性疾患の世界市場（～2026年） The bleeding disorder is a condition in which there is a problem associated with the normal blood clotting process in the body, which gets affected. Hence, therapies to stop bleeding are on high demand. Market Analysis and Insights: Global Bleeding Disorders Market The global Bleeding Disorders mark…
- 神経精神障害・治療の世界市場（～2026年） Neuropsychiatric disorder is a blanket medical term that encompasses a broad range of medical conditions that involve both neurology and psychiatry. Common neuropsychiatric disorders include seizures, attention deficits, cognitive deficits, palsies, uncontrolled anger, migraine headaches, addictions…